Structure and function of retroviral integrase

GN Maertens, AN Engelman… - Nature Reviews …, 2022 - nature.com
A hallmark of retroviral replication is establishment of the proviral state, wherein a DNA copy
of the viral RNA genome is stably incorporated into a host cell chromosome. Integrase is the …

New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates?

E Ndashimye, PS Reyes, EJ Arts - FEMS Microbiology Reviews, 2023 - academic.oup.com
Combined HIV antiretroviral therapy (cART) has been effective except if drug resistance
emerges. As cART has been rolled out in low-income countries, drug resistance has …

Dolutegravir resistance in sub-Saharan Africa: should resource-limited settings be concerned for future treatment?

D Kamori, G Barabona - Frontiers in Virology, 2023 - frontiersin.org
In sub-Saharan Africa (SSA) the burden of non-nucleoside reverse transcriptase inhibitor
(NNRTI) HIV drug resistance (HIVDR) has been high over the years. Therefore, in 2018 the …

Exploring the mechanisms behind HIV drug resistance in sub-Saharan Africa: conceptual mapping of a complex adaptive system based on multi-disciplinary expert …

A Kiekens, B Dierckx de Casterlé, G Pellizzer… - BMC Public Health, 2022 - Springer
Background HIV drug resistance (HIVDR) continues to threaten the effectiveness of
worldwide antiretroviral therapy (ART). Emergence and transmission of HIVDR are driven by …

Pre-treatment integrase inhibitor resistance and natural polymorphisms among HIV-1 subtype C infected patients in Ethiopia

DA Arimide, ZI Szojka, K Zealiyas, A Gebreegziabxier… - Viruses, 2022 - mdpi.com
Dolutegravir-based antiretroviral therapy (ART) has been scaled up in many developing
countries, including Ethiopia. However, subtype-dependent polymorphic differences might …

High-level resistance to bictegravir and cabotegravir in subtype A-and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations

E Ndashimye, Y Li, PS Reyes, M Avino… - Journal of …, 2021 - academic.oup.com
Objectives The second-generation integrase strand transfer inhibitor (INSTI) bictegravir is
becoming accessible in low-and middle-income countries (LMICs), and another INSTI …

New designs for HIV-1 integrase inhibitors: a patent review (2018-present)

Y Taoda, S Sugiyama, T Seki - Expert Opinion on Therapeutic …, 2023 - Taylor & Francis
Introduction Combination antiretroviral therapy (cART) has dramatically reduced morbidity
and mortality of HIV-1-infected patients. Integrase strand transfer inhibitors (INSTIs) play an …

Viral load suppression and HIV-1 drug resistance mutations in persons with HIV on TLD/TAFED in Zambia

EL Luwaya, L Mwape, K Bwalya, C Siakabanze… - Plos one, 2024 - journals.plos.org
Background An increase in the prevalence of HIV drug resistance (HIVDR) has been
reported in recent years, especially in persons on non-nucleoside reverse transcriptase …

[HTML][HTML] Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase …

DH Gouissi Anguechia, Y Bouba, ENJ Semengue… - Viruses, 2024 - mdpi.com
Dual therapies (DT) combining integrase strand transfer inhibitors (INSTIs) with second-
generation non-nucleoside reverse transcriptase inhibitors (2nd-Gen-NNRTIs) offer new …

Patterns of Transmitted Drug Resistance Mutations and HIV-1 Subtype Dynamics in ART-Naïve Individuals in Veneto, Italy, from 2017 to 2024

N Geremia, M Basso, A De Vito, R Scaggiante… - …, 2024 - pmc.ncbi.nlm.nih.gov
This study investigates the prevalence and patterns of transmitted drug resistance mutations
(TDRMs) and HIV-1 subtypes among antiretroviral therapy (ART) naïve individuals in …